Insider Transactions in Q4 2022 at Hanger, Inc. (HNGR)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 03
2022
|
Kathryn M Sullivan Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
62,026
-100.0%
|
$1,116,468
$18.75 P/Share
|
|
Oct 03
2022
|
Richard Pettingill Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
78,135
-100.0%
|
$1,406,430
$18.75 P/Share
|
|
Oct 03
2022
|
Cynthia L Lucchese Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
67,851
-100.0%
|
$1,221,318
$18.75 P/Share
|
|
Oct 03
2022
|
Mark M Jones Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,594
-100.0%
|
$370,692
$18.75 P/Share
|
|
Oct 03
2022
|
Stephen E Hare Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
107,009
-100.0%
|
$1,926,162
$18.75 P/Share
|
|
Oct 03
2022
|
Thomas E Hartman SVP and General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
153,580
-100.0%
|
$2,764,440
$18.75 P/Share
|
|
Oct 03
2022
|
Keri Jolly SVP & Chief HR Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
44,411
-100.0%
|
$799,398
$18.75 P/Share
|
|
Oct 03
2022
|
Thomas E Kiraly EVP & Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
276,451
-100.0%
|
$4,976,118
$18.75 P/Share
|
|
Oct 03
2022
|
Kathleen L Means Chief Supply Chain Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,760
-100.0%
|
$103,680
$18.75 P/Share
|
|
Oct 03
2022
|
Michael H Oros President, Hanger Clinic |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,889
-100.0%
|
$304,002
$18.75 P/Share
|
|
Oct 03
2022
|
Scott Ranson EVP, Chief Info Officer * |
SELL
Sale (or disposition) back to the issuer
|
Direct |
117,479
-100.0%
|
$2,114,622
$18.75 P/Share
|
|
Oct 03
2022
|
Peter A Stoy EVP & Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
65,190
-100.0%
|
$1,173,420
$18.75 P/Share
|
|
Oct 03
2022
|
John T Fox Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
43,561
-100.0%
|
$784,098
$18.75 P/Share
|
|
Oct 03
2022
|
Thomas C Freyman Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
43,561
-100.0%
|
$784,098
$18.75 P/Share
|
|
Oct 03
2022
|
Mitchell D Dobson SVP, Chief Compliance Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
42,840
-100.0%
|
$771,120
$18.75 P/Share
|
|
Oct 03
2022
|
James H Campbell SVP, Chief Clinical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
52,391
-100.0%
|
$943,038
$18.75 P/Share
|
|
Oct 03
2022
|
Christopher B Begley Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
76,414
-100.0%
|
$1,375,452
$18.75 P/Share
|
|
Oct 03
2022
|
Asif Ahmad Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
70,837
-100.0%
|
$1,275,066
$18.75 P/Share
|
|
Oct 03
2022
|
Gabrielle B. Adams Vice President Accounting |
SELL
Sale (or disposition) back to the issuer
|
Direct |
68,930
-100.0%
|
$1,240,740
$18.75 P/Share
|
|
Oct 03
2022
|
Gabrielle B. Adams Vice President Accounting |
SELL
Bona fide gift
|
Direct |
2,442
-4.05%
|
-
|
|
Oct 03
2022
|
Vinit K Asar President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
929,994
-100.0%
|
$16,739,892
$18.75 P/Share
|
|
Oct 03
2022
|
Vinit K Asar President and CEO |
SELL
Bona fide gift
|
Direct |
10,597
-1.44%
|
-
|